SEC Form 4 · accession 0001209191-18-062127

Tempest Therapeutics, Inc. · TPST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 7, 2018

Accepted (ET)

Dec 11, 2018 · 7:49 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001544227

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 7, 2018	A	15,784	—	A	15,784	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3,F2	$4.44	Dec 7, 2018	A	21,438	A	—	Jan 27, 2026	Common Stock	21,438	21,438	D
Stock Option (right to buy)^F5,F4	$16.40	Dec 7, 2018	A	3,720	A	—	Aug 23, 2028	Common Stock	3,720	3,720	D

F1Received in exchange for 212,163 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").
F2Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F3Received in connection with the Merger in exchange for a stock option to acquire 288,152 shares of Millendo common stock for $0.33 per share.
F4Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F5Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share.